Original BioMedicals Co., Ltd. (TPEX:6483)
15.60
+0.15 (0.97%)
Feb 11, 2026, 2:59 PM CST
Original BioMedicals Revenue
Original BioMedicals had revenue of 381.00K TWD in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 381.00K, up 786.05% year-over-year.
Revenue (ttm)
381.00K
Revenue Growth
+786.05%
P/S Ratio
2,716.73
Revenue / Employee
16.57K
Employees
23
Market Cap
1.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 43.00K | -64.00K | -59.81% |
| Dec 31, 2022 | 107.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Excelsior Biopharma | 898.26M |
| Anxo Pharmaceutical | 883.22M |
| Prince Pharmaceutical | 798.27M |
| Winston Medical Supply | 724.35M |
| DV Biomed | 712.61M |
| GeneFerm Biotechnology | 654.88M |
| Tien Liang BioTech | 467.02M |
| General Biologicals | 251.38M |